Moyamoya syndrome associated with Sneddon's syndrome and antiphospholipid-protein antibodies

Journal of Stroke and Cerebrovascular Diseases

Volumn 8, Issue 2, 1999, Pages 51-56

  Carhuapoma, Juan R ^a   D'Olhaberriague, Luis ^a   Levine, Steven R ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Anticardiolipin Antibodies; Antiphospholipid Antibodies; Livedo Reticularis; Lupus Anticoagulant; Moyamoya; Sneddon's Syndrome

Indexed keywords

EID: 77950208857     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3057(99)80054-8     Document Type: Review

References (43)

1. Garg B.P., Bruno A., and Biller J. Moyamoya Disease and Cerebral Ischemia. In: Batjer H.H. (Ed). Cerebrovascular Disease. 1st Ed (1997), Lippincott-Raven Publishers, Philadelphia 489-499
2. Seeler R.A., Royal J.E., and Powe L. Moyamoya in children with sickle cell anemia and cerebrovascular occlusion. J Pediatr 93 (1978) 808-810
3. Merkel K.H.H., Ginsberg P.L., and Parker Jr. J.C. Cerebrovascular disease in sickle cell anemia: A clinical, pathological and radiologic correlation. Stroke 9 (1978) 45-52
4. Erickson R.P., Woolliscroft J., and Allen R.J. Familial occurrence of intracranial arterial occlusive disease (Moyamoya) in neurofibromatosis. Clin Genet 18 (1980) 191-196
5. Lamas E., Diez L.R., and Cabello A. Multiple intracranial arterial occlusions (Moyamoya disease) in patients with neurofibromatosis. One case report with autopsy. Acta Neurochir 45 (1978) 133-145
6. Levine S.R., Fagan S.C., Pessin M.S., et al. Accelerated intracranial occlusive disease, oral contraceptives and cigarette use. Neurology 41 (1991) 1893-1901
7. Pilz P., and Hartjes H.J. Fibromuscular dysplasia and multiple dissecting aneurysms of intracranial arteries: A further cause of Moyamoya syndrome. Stroke 7 (1976) 393-398
8. Gordon N., and Isler W. Childhood moyamoya disease. Dev Med Child Neurol 31 (1991) 98-107
9. Chaudhuri K.R., and Edwards R. Adult moyamoya disease. Br Med J 307 (1993) 852-854
10. Sneddon I.B. Cardiovascular lesions and livedo reticularis. Br J Dermatol 77 (1965) 180-185
11. Quimby S.R., and Perry H.O. Livedo reticularis and cerebrovascular accidents. J Am Acad Dermatol 3 (1980) 377-383
12. Rebollo M., Val J.F., Garijo F., et al. Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome): Clinical, radiological and pathologic features in eight cases. Brain 106 (1983) 965-979
13. Levine S.R., Langer S.L., Albers J.W., et al. Sneddon's syndrome: An antiphospholipid antibody syndrome?. Neurology 38 (1988) 798-800
14. Stockhammer G., Felber S., Zelger B., et al. Sneddon's syndrome: Diagnosis by skin biopsy and MRI in 17 patients. Stroke 24 (1993) 685-690
15. Kalashnikova L.A., Nasonov E.L., Stoyanovich L.Z., et al. Anticardiolipin antibodies in Sneddon's syndrome. Neurology 40 (1994) 464-467
16. Kalashnikova L.A., Nasonov E.L., Stoyanovich L.Z., et al. Sneddon's syndrome and the primary antiphospholipid syndrome. Cerebrovasc Dis 4 (1998) 76-82
17. Debrun G., Sauvegrain J., Aicardi J., et al. Moyamoya, a nonspecific radiological syndrome. Neuroradiology 8 (1975) 241-244
18. Yonekawa Y., Handa H., and Okuno T. Moyamoya disease: Diagnosis, treatment and recent achievement. In: Barnett H.J.M., Mohr J.P., Stein B.M., and Yatsu F.M. (Eds). Stroke. Pathophysiology, Diagnosis, and Management. 1st Ed (1986), Churchill Livingstone, New York 805-829
19. Hosoda Y. A pathomorphological study of the so called "spontaneous occlusion of the circle of Willis" (cerebrovascular Moyamoya disease). Folia Angiologia 24 (1998) 85-86
20. Osborn A.G. Stroke. In: Osborn A.G. (Ed). Diagnostic Neuroradiology. 1st Ed (1994), Mosby, St. Louis 330-398
21. Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome. J Rheumatol 19 (1992) 1778-1781
22. The Antiphospholipid Antibodies in Stroke Study Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 21 (1990) 1268-1273
23. Love P.E., and Santoro S.A. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Ann Intern Med 112 (1990) 682-698
24. Feldmann E., and Levine S.R. Cerebrovascular disease with antiphospholipid antibodies: Immune mechanisms, significance, and therapeutic options. Ann Neurol 37 S1 (1995) S114-S130
25. Levine S.R. Antiphospholipid antibodies and the nervous system. Semin Neurol 14 (1994) 168-178
26. Vermylen J., Blockmans D., Spitz B., et al. Thrombosis and immune disorders. Clin Haematol 15 (1986) 33-412
27. Champion R.H., and Rook A.J. Livedo reticularis. Proc R Soc 53 (1960) 961-962
28. Johnson R.T., and Richardson E.P. The neurologic manifestations of systemic lupus erythematosus. Medicine 47 (1968) 337-369
29. Yamashita M.a.^K., and Tanaka K. Histopathology of the brain vascular network in moyamoya disease. Stroke 14 (1983) 50-58
30. Suzuki J., Takaku A., and Fukusawa H. Cerebrovascular "Moyamoya" disease among the Japanese, on study of an autopsy case. Neurologia Med Chir (Tokyo) 8 (1966) 269-270
31. Maki Y., and Nakata Y. An autopsy case of hemangiomatous malformation of bilateral carotid artery at the base of the brain. No To Shinkei 17 (1965) 262-263
32. Geschwind D.H., FitzPatrick M., Mischel P.S., et al. Sneddon's syndrome is a thrombotic vasculopathy: Neuropathologic and neuroradiologic evidence. Neurology 45 (1995) 557-560
33. Pettee A.D., Wasserman B.A., Adams N.L., et al. Familial Sneddon's syndrome: Clinical, hematologic and radiographic findings in two brothers. Neurology 44 (1994) 399-405
34. Scott I.A., and Boyle R.S. Sneddon's syndrome. Aust N Z J Med 16 (1986) 799-802
35. Nomura T. Atlas of Cerebral Angiography. 1st Ed (1961), Igakushoin, Tokyo 192-194
36. Takeuchi K. Occlusive disease of the carotid artery. Recent advances in research of the nervous system. Recent Adv Res Nerv Syst 5 (1961) 511-543
37. Adams H.P., Kassell N.F., Wisoff H.S., and Drake C.G. Intracranial saccular aneurysm and moyamoya disease. Stroke 10 (1979) 174-179
38. Aoki N., and Mizutani H. Does moyamoya disease cause subarachnoid hemorrhage? Review of 54 cases with intracranial hemorrhage confirmed by computerized tomography. J Neurosurg 60 (1984) 348-353
39. Konishi Y., Kadowaki C., Hara M., et al. Aneurysms associated with moyamoya disease. Neurosurgery 16 (1985) 489-491
40. Yamashita M., Tanaka K., Matsuo T., et al. Cerebral dissecting aneurysms in patients with moyamoya disease. J Neurosurg 58 (1983) 120-125
41. Fujiwara S., Miyazono M., Tsuda H., et al. Intraventricular hemorrhage and cerebral ischemic attacks in the presence of lupus anticoagulant mimicking Moyamoya disease. J Neurosurg Sci 37 (1993) 161-164
42. Leno C., Mateo I., Cid C., et al. Autoimmunity in Down's syndrome: Another possible mechanism of moyamoya disease. Stroke 29 (1998) 868-869
43. Inoue R., Katayama S., Kasai N., et al. Middle cerebral artery occlusion with unilateral moyamoya like vessels and with ruptured anterior cerebral artery aneurysm-its relation to the antiphospholipid antibody syndrome. No To Shinkei 46 (1994) 995-998